# A Phase 1 Study of LNCB74 in Advanced Solid Tumors

> **NCT06774963** · PHASE1 · RECRUITING · sponsor: **NextCure, Inc.** · enrollment: 145 (estimated)

## Conditions studied

- Ovarian Cancer
- Breast Cancer
- Endometrial Cancer
- Biliary Tract Cancer
- Non-Small Cell Lung Cancer
- Advanced or Metastatic Solid Tumors

## Interventions

- **DRUG:** LNCB74

## Key facts

- **NCT ID:** NCT06774963
- **Lead sponsor:** NextCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774963, "A Phase 1 Study of LNCB74 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06774963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*